Alnea Chosen as Tradename for Watson’s Hormone Replacement Patch
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Watson plans to use the name Alnea for its combination estradiol/progestin transdermal patch for treatment of vasomotor symptoms in postmenopausal women with an intact uterus. The firm submitted the names Estrapro, Alnea-SQ, Alnea-CC and Alneta SQ to the Patent and Trademark Office for a transdermal hormone replacement patch.